VRCA vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

VRCA

34.6
AI Score
VS
CLYM Wins

CLYM

50.9
AI Score

Investment Advisor Scores

VRCA

35score
Recommendation
SELL

CLYM

51score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric VRCA CLYM Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -53.9% 0.0% CLYM
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 34.6/100 50.9/100 CLYM
Profit Margin -102.8% 0.0% CLYM
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD CLYM

Relative Price Performance (Last 90 Days)

VRCA 1M: -3.5% · 3M: -18.5% CLYM 1M: -1.0% · 3M: +30.6%

Current Technical Phase

VRCA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.3%), weak momentum, RSI 42

RSI (14): 42.4 · Price: $4.91

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.8 · Price: $14.25

Fundamentals Snapshot

Metric VRCA CLYM
Market Cap
Forward P/E -3.3 -14.2
Trailing P/E
Revenue (TTM)
Revenue Growth -0.5% 0.0%
Gross Margin 0.4%
Operating Margin -1.9% 0.0%
EPS -1.70 -0.82
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.